Shilpa Medicare Board of Directors

Get the latest insights into the leadership at Shilpa Medicare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Omprakash Inani Chairman
Mr. Vishnukant C Bhutada Managing Director
Mr. Kalakota Sharath Reddy Whole Time Director
Mr. Hetal Madhukant Gandhi Independent Director
Mr. Arvind Vasudeva Independent Director
Dr. Kamal K Sharma Independent Director
Dr. Anita Bandyopadhyay Independent Woman Director

Shilpa Medicare Share price

SHILPAMED

850.45

4.20 (0.50%)
NSE
BSE
Last updated on 1 Sep, 2025 | 15:57 IST
BUYSELL
Today's High

854.75

Today's Low

829.10

52 Week Low

555.00

52 Week High

1000.00

The current prices are delayed, login to your account for live prices

Shilpa Medicare FAQs

The board at Shilpa Medicare consists of experienced professionals, including Mr. Omprakash Inani , Mr. Vishnukant C Bhutada , and others, overseeing the company’s strategic and corporate governance.

Directors at Shilpa Medicare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Omprakash Inani is the current chairman at Shilpa Medicare.

Executive directors at Shilpa Medicare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Shilpa Medicare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Shilpa Medicare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.